BBI - Brickell Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
+0.1400 (+3.20%)
At close: 4:00PM EDT

4.5200 0.00 (0.00%)
Pre-Market: 8:00AM EDT

Stock chart is not supported by your current browser
Previous Close4.3800
Bid0.0000 x 1200
Ask0.0000 x 2200
Day's Range4.3300 - 4.5600
52 Week Range4.0200 - 10.1500
Avg. Volume94,863
Market Cap35.305M
Beta (3Y Monthly)-0.13
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.80
Trade prices are not sourced from all markets
  • GlobeNewswire

    Brickell Biotech Completes Merger with Vical

    Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company, today announced the completion of its merger with Vical Incorporated (“Vical”), following approval by Vical’s stockholders.

  • We're sorry this is all we were able to find about this topic.